Table 1 Baseline characteristics of patients.
| Vital status at 1‐year follow‐up | Univariate predictor for mortality (OR, 95% CI) | p Value | ||
|---|---|---|---|---|
| Alive (n = 3666) | Dead (n = 120) | |||
| Male sex (%) | 2785 (76) | 93 (78) | 1.09 (0.70 to 1.68) | 0.71 |
| Mean (SD) age (years) | 62.8 (10.6) | 69 (9.9) | 1.06 (1.04 to 1.08) | <0.001 |
| Risk factors (%) | ||||
| Smoking ever | 2166 (61) | 75 (63) | 1.05 (0.72 to 1.53) | 0.79 |
| Diabetes mellitus | 850 (23) | 43 (36) | 1.85 (1.26 to 2.70) | 0.002 |
| Hypertension | 2254 (62) | 75 (63) | 1.04 (0.71 to 1.51) | 0.85 |
| Hyperlipidaemia | 2417 (67) | 78 (66) | 0.98 (0.66 to 1.44) | 0.9 |
| Cardiovascular history (%) | ||||
| Peripheral vascular disease | 412 (11) | 32 (27) | 2.87 (1.89 to 4.35) | <0.001 |
| Cerebral vascular disease | 283 (8) | 12 (10) | 1.33 (0.72 to 2.44) | 0.36 |
| Prior myocardial infarction | 1440 (39) | 72 (60) | 2.31 (1.59 to 3.35) | <0.001 |
| Congestive heart failure | 673 (18) | 50 (42) | 3.17 (2.19 to 4.61) | <0.001 |
| Prior percutaneous coronary intervention | 764 (21) | 19 (16) | 0.71 (0.43 to 1.17) | 0.18 |
| Prior coronary artery bypass grafting | 368 (10) | 24 (20) | 2.24 (1.41 to 3.55) | <0.001 |
| Diagnosis at admission (%) | ||||
| Stable angina | 1978 (55) | 60 (52) | 0.85 (0.59 to 1.23) | 0.39 |
| NSTE‐ACS | 1105 (31) | 40 (35) | 1.16 (0.79 to 1.71) | 0.45 |
| STEMI | 537 (15) | 16 (14) | 0.90 (0.53 to 1.53) | 0.90 |
| Angiographic results (%) | ||||
| Multivessel disease | 2308 (63) | 89 (74) | 1.68 (1.11 to 2.54) | 0.01 |
| Left main lesions | 284 (8) | 15 (13) | 1.70 (0.98 to 2.96) | 0.06 |
| Ejection fraction <40% | 296 (12) | 34 (37) | 4.25 (2.74 to 6.60) | <0.001 |
| Mean (SD) EuroSCORE | 4.2 (2.8) | 6.8 (3.4) | 1.28 (1.21 to 1.35) | <0.001 |
| Treatment option (%) | ||||
| Percutaneous coronary intervention | 2201 (60) | 54 (45) | 0.55 (0.38 to 0.79) | 0.001 |
| Coronary artery bypass grafting | 745 (20) | 22 (18) | 0.88 (0.55 to 1.41) | 0.59 |
| Only medical treatment | 720 (20) | 44 (37) | 2.37 (1.62 to 3.46) | <0.001 |
| Medical treatment at discharge (%) | ||||
| Antiplatelet agents/oral anticoagulants | 3464 (95) | 105 (88) | 0.41 (0.23 to 0.71) | 0.002 |
| β‐blockers | 2796 (76) | 86 (72) | 0.79 (0.53 to 1.18) | 0.25 |
| Statins | 2498 (68) | 71 (59) | 0.68 (0.47 to 0.98) | 0.04 |
| ACE inhibitors | 2027 (55) | 76 (63) | 1.40 (0.96 to 2.04) | 0.08 |
NSTE‐ACS, non ST‐elevation acute coronary syndrome; STEMI, ST‐elevation myocardial infarction